NCT06281600View on ClinicalTrials.gov

An Intervention Study Using HMOs to Improve IBS Symptoms

NARecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

August 20, 2025

Study Completion Date

September 20, 2025

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Human milk oligosaccharide

5g daily dose of HMOs.

DIETARY_SUPPLEMENT

Maltodextrin placebo

5g daily dose of maltodextrin.

Trial Locations (1)

RG6 6LA

RECRUITING

The University of Reading, Reading

All Listed Sponsors
collaborator

Royal Berkshire NHS Foundation Trust

OTHER_GOV

lead

Glenn Gibson

OTHER